Pending share supply of ~26.0 million equals 385% of the ~6.75 million share float, and that figure conservatively excludes the full ELOC capacity — the Company's own estimate of maximum shares issuable under the C/M equity line is 43,750,000, or 6.5x the entire current float, against $30.8 million of remaining undrawn capacity versus a ~$2.8 million market cap at $0.41. Three mechanisms are live and firing right now: (1) the C/M ELOC, drawn continuously — 2,616,448 shares for $2.95M in H1 2026, 2,308,012 shares for $1.27M from 7/1 to 8/18, and 510,951 shares on 8/25 at $0.2106, with each draw priced at 95% of the LOWER of the 5-day VWAP and the lowest trading price of the day, plus a downward purchase-price reset to any lower New Issuance Price within three business days; (2) $2.7 million of floating-rate convertible notes convertible at the lower of $7.00 and $0.04 above the closing price — a formula with no meaningful floor that mechanically issues more shares as the price falls, and the Company itself now discloses 3,899,658 shares underlying converts; (3) preferred conversion overhang of 10.6–11.3 million shares plus 1,021,745 shares of stock-payable dividends, including the new Series D ($5.5M stated value, $1.00 conversion with a full-ratchet reset to a $0.60 floor = up to 9,166,667 shares). Add a 2,093,250-share Strategic Transformation RSU plan (20% of fully diluted) and fresh 431,250-option grants to the new interim CEO/COO. The only component that is NOT dangerous is the warrant book: 1,875,384 warrants at a $41.20 weighted-average strike are ~100x out of the money with no disclosed reset, contributing essentially zero. Score is 9 rather than 10 solely on that dead warrant overhang; every other component is maxed.